Cosalane is a novel anti-HIV agent that inhibits the attachment of gp120 to
CD4. The therapeutic potential of cosalane is limited by poor oral absorpt
ion. In an attempt to target the ileal bile acid transporter and thus facil
itate oral bioavailability, a cosalane analog was synthesized in which the
disalicylmethane pharmacophore is attached to a bile acid through a linker
chain appended to C-17 of the steroid nucleus. The resulting bile acid anal
og of cosalane, retained antiviral activity vs. HIV-1(IIIB) and HIV-2(ROD)
in MT-4 cells, but was less potent than cosalane. (C) 2001 Elsevier Science
Ltd. All rights reserved.